1356920-05-2

Upstream product

• 1008742-67-3 3-{4-[(4S)-4-benzyl-2-oxo-1,3-thiazolidin-3-yl]-4-oxobutyl}-1,2,3-benzotriazin-4(3H)-one 
• 555-16-8 4-nitrobenzaldehdye 

Downstream Products

• 1356920-08-5 N-{4-[(1S,2S)-2-{[(4S)-4-benzyl-2-oxo-1,3-thiazolidin-3-yl]carbonyl}-1-hydroxy-4-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)butyl]phenyl}-4-ethylbenzamide 
• 1356919-37-3 (2S)-2-[(S)-(4-{[(4-ethylphenyl)carbonyl]amino}phenyl)(hydroxy)methyl]-4-(4-oxo-1,2.3-benzotriazin-3(4H)-yl)butanoic acid 
• 1356919-73-7 (2S)-2-[(S)-(4-{[(3-chloro-2,6-difluorophenyl)carbonyl]amino}phenyl)(hydroxy)methyl]-4-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)butanoic acid 
• 1356920-06-3 3-[(3S,4S)-4-(4-aminophenyl)-3-{[(4S)-4-benzyl-2-oxo1,3-thiazolidin-3-yl]carbonyl}-4-hydroxybutyl]-1,2,3-benzotriazin-4(3H)-one 
• 1356920-07-4 N-{4-[(1S,2S)-2-{[(4S)-4-benzyl-2-oxo-1,3-thiazolidin-3-yl]carbonyl}-1-hydroxy-4-(4-oxo-1,2,3-benzotriazin-3(4H)-yl)butyl]phenyl}-2-fluoro-4-(trifluoromethyl)benzamide 

Relevant academic research and scientific papers

MATRIX METALLOPROTEINASE INHIBITORS

The present invention relates to certain hydroxy propionic acid derivatives and the processes for the synthesis of the same. This invention also relates to pharmacological compositions containing the compounds of the present invention, and methods of trea